Tildrakizumab-asmn Subcutaneous and Vancenase AQ
Determining the interaction of Tildrakizumab-asmn Subcutaneous and Vancenase AQ and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
Generic Name: beclomethasone nasal
Brand name: Beconase AQ, QNASL, Beconase, Vancenase, Vancenase AQ, Vancenase AQ DS, QNASL
Synonyms: Vancenase AQ (Nasal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tildrakizumab-asmn Subcutaneous-Vancenase AQ Double Strength
- Tildrakizumab-asmn Subcutaneous-Vancocin
- Tildrakizumab-asmn Subcutaneous-Vancocin HCl
- Tildrakizumab-asmn Subcutaneous-Vancocin HCl Pulvules
- Tildrakizumab-asmn Subcutaneous-Vancoled
- Tildrakizumab-asmn Subcutaneous-Vancomycin
- Vancenase AQ-Tilia Fe
- Vancenase AQ-Tiludronate
- Vancenase AQ-Timentin
- Vancenase AQ-Timentin Add-Vantage
- Vancenase AQ-Timentin Injection
- Vancenase AQ-Timentin Novaplus